Springer Nature
Browse
12935_2019_732_MOESM2_ESM.tif (5.08 MB)

MOESM2 of Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

Download (5.08 MB)
figure
posted on 2019-01-11, 05:00 authored by Yuyang Liu, Xiangnan Hu, Xuefeng Shan, Ke Chen, Hua Tang
Additional file 2: Figure S2. Weight curves of the nude mice were analyzed.

Funding

the basic research and frontier exploration project of Yuzhong District of Chongqing

History

Usage metrics

    Cancer Cell International

    Categories

    Keywords

    Rosiglitazone metformin adductHepatocellular carcinomaProliferationMetforminAMPK/p21 pathway

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC